Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • XLB vs GSK✓SelectedUSD · GSKXLB vs GSK performance historyLatest closeAs of-1.22%11/17
Stock and ETF performance explorer

XLB vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+34.2%
GSK return
+58.9%
Excess return
-24.7%
Maximum drawdown
-23.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.2%-2.3%+1.1%-0.8%
7D-3.8%-3.0%-0.8%-3.2%
30D-0.2%+0.4%-0.5%-0.3%
3M-2.2%-1.2%-1.0%-2.1%
6M+1.9%+0.9%+1.0%+1.6%
YTD+13.5%+4.0%+9.6%+12.4%
1Y+21.1%+7.3%+13.8%+19.3%
3Y+34.2%+57.1%-22.9%+20.5%
All+34.2%+58.9%-24.7%+20.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling